Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
86 Cards in this Set
- Front
- Back
Characteristic changes neurons exhibit in response to injury
|
Central chromatolysis
Axonal degeneration Degeneration of surrounding myelin (secondary demyelination) |
|
Central chromatolysis: defn
|
swelling of cell body with dispersion of organelles to periphery
|
|
Two other pathological changes that nervous system cells other than neurons exhibit
|
Reactive astrocytosis (gliosis)
Microglial proliferation |
|
T/F CNS has few lymphatics.
|
F. CNS has NO lymphatics.
|
|
arachnoid granulations - defn
|
site of resorption of CSF into the dural venous sinuses
|
|
lipofuscin: defn
|
a brown oxidation product that accumulations in aging neurons
|
|
Neuromelanin: where?
|
substantia nigra, locus ceruleus (site of catecholamine product)
|
|
T/F Albinos are missing neuromelanin
|
F. Neuromelanin isn't formed via tyrosine OH-ase, like melanin in skin and eye.
|
|
appearance of necrotic neurons
|
<b>bright red (red is dead)</b> with shrunken pyknotic nuclei.
|
|
pyknosis: defn
|
irreversible condensation of chromatin in the nucleus of a cell undergoing necrosis or apoptosis.
|
|
Pyknosis is immediately followed by ___________, or fragmentation of the nucleus.
|
karyhorrhexis
|
|
T/F Cells undergoing apoptosis incite the inflammatory response
|
F.
|
|
Neuronal inclusions: AD
|
Neurofibrillary tangles
|
|
Neuronal inclusions: PD
|
Lewy bodies
|
|
Neuronal inclusions: Rabies
|
Negri bodies : intracytoplasmic inclusions
|
|
Neuronal inclusions: Storage diseases (ie., Tay Sachs)
|
Swollen neuronal cell bodies, full of lipid storage material. It distends and disables the neurons.
|
|
Central chromatolysis: cause (general)
|
Injury far from cell body. The movements of organelles to the periphery with a central clear zone (hence, "central chromatolysis") is in response to retrograde signal from injured axon.
The cell body is prepping to make new protein that travels downstream to repair the injured axon. |
|
Changes that occur distal to the point of axonal injury are termed ____________
|
wallerian degeneration
|
|
In wallerian degeneration, Schwann cells breakdown why?
|
secondary to loss of tropic input from axon
|
|
primary axonal injury: defn
|
injury that is begun by an insult directly to the axon.
|
|
What would an infarct within the internal capsule do?
|
Would see degeneration of the corticospinal tract due to loss of trophic interaction (antero- and retrograde transport).
|
|
Why does the PNS regenerate axons, but the CNS does not?
|
In the PNS, Schwann cells proliferate and form a tube directing the regenerating axon to reinnervate its normal target.
In the CNS, the oligodendroglia don't do this. Thus, even though CNS neurons are sprouting at the injured end, no one directs the traffic so it can't find its location. |
|
Dying back neuropathy is aka
|
distal axonopathy
|
|
distal axonopathy: defn
|
Axon dies near its termination point --> patches of injury appear at successively more proximal regions (closer and closer to cell body) as the process continues. Often seen after injury from toxins and in some metabolic neuropathies.
|
|
distal axonopathy: what type of injury/insult causes it?
|
usually metabolic/toxic.
|
|
segmental demyelination: defn
|
primary injury to the myelin. Axons die in patchy fashion.
|
|
two major types of glia
|
Microglia
Macroglia |
|
Microglia are derived from _______
|
mesoderm
|
|
Macroglia are derived from _______
|
neuroectoderm
|
|
Special stain for astroglia
|
GFAP
|
|
The Astrocyte Barrier: defn
|
Astocytes enclose the entire CNS parenchyma - under the pia, form the BBB, etc.
|
|
reactive astrocytes: defn
|
astrocytes that have responded to non-specific CNS injury
|
|
Virchow-Robin spaces (VRS): defn
|
perivascular, fluid-filled canals that surround perforating arteries and veins in the parenchyma of the brain
|
|
What forms the BBB?
|
Tight junctions between endothelial cells. This barrier also includes a thick basement membrane and astrocytic endfeet.
|
|
Reactive astrocytosis: defn
|
(aka "glial scar")
Astrocytes proliferating around necrotic brain in an attempt to impart/restore normal BBB functions to blood vessels that proliferate in and around the site of injury. |
|
T/F Glial scar contains collagen
|
F
|
|
Appearance of oligodendroglia nuclei
|
Dark and Round (looks like "O")
|
|
T/F Each oligodendrocyte provides myelination to multiple CNS axons.
|
T
|
|
Progressive Multifocal Leukoencephalopathy: pathophys
|
JC virus attacks oligodendroglia, resulting in demyelination.
Occurs in immunocompromised. |
|
When a disease contains "leuko" think what?
|
myelin-related
|
|
What are the consequences of the fact that oligodendroglia repel growing axons?
|
May be a factor preventing successful regeneration of axons in the CNS. May redirect axons attempting to pursue the normal pathways, resulting in jumble of axon growth cones that give up.
|
|
The JC virus is what type of virus?
|
polyoma
|
|
Ependymal cells: purpose and fxn
|
form the ventricle lining. Have epithelial and glial features. No unique response to injury.
|
|
The resident mononuclear cell of the brain (originate from bone marrow)
|
microglia
|
|
Microglia proliferate in what diseases?
|
Viral, Rickettsial, or Spirochete encephalitis
|
|
Microglia : derivation
|
mesodermal (bone marrow)
|
|
neuronophagia: defn
|
Surrounding and phagocytosis of dying/dead neuron by microglia
|
|
Rod cells: defn
|
Activated microglia
|
|
Choroid Plexus: defn
|
Organ/Cells responsible for generation of CSF
|
|
Arachnoid cap cells
are aka |
meningothelial cells
|
|
meningothelial cells: what do they do?
|
Line arachnoid granulations at dural venous sinuses where CSF is resorbed.
|
|
meningothelial cells: rxn to injury
|
hyperplasia
|
|
Changes in gene function without changes in gene sequence
|
epigenetics
|
|
phakomatoses: defn
|
"neurocutaneous syndromes" are disorders of central nervous system that additionally result in lesions on the skin and the eye.
|
|
Tay-Sachs: symptoms
|
Psychomotor retardation with hypotonia and blindness, plus hyperacusis, macular cherry-red spot, and megalencephaly without visceromegaly.
|
|
Phakomatoses effect this cell layer, producing the neurocutaneous syndromes
|
ectoderm
|
|
First part of genetic testing
|
Family history
|
|
Test Candidate for Diagnostic test
|
Symptomatic patient
|
|
Test Candidate for Prenatal testing
|
Pregnant symptomatic or at-risk individual or carrier couple
|
|
Test Candidate for Predictive testing
|
1) asymptomtic individuals with known family history of disease (ie., HD)
2) Newborn screening - for diseases that are TREATABLE |
|
Test Candidate for Carrier testing
|
those where autosomal recessive and x-linked d/os suspected.
Screening populations with high frequency of carriers |
|
___ inheritance underlies many of the “metabolic” disorders
|
auto recessive
|
|
Typically due to loss of function
|
autosomal recessive disorders
|
|
phenocopy-defn
|
clinical expression similar to genetic disease but actually caused by an environmental factor
|
|
lack of penetrance: defn
|
Carriers of dominant disease having mild or no clinical expression of the gene mutation they carry
|
|
What type of chromosomal aberration does markedly increase risk for recurrence in additional pregnancies?
|
balanced translocation
|
|
imprinting: defn
|
germ line specific modification of chromsomes, resulting in different expression of genetic info depending on whether it was inherited maternally or paternally.
|
|
Methlyation (activates, deactivates) gene expression while acetylation (activates, deactivates).
|
deactivates; activates
|
|
Rett's syndrome: defn and pathophys
|
Acquired microcephaly with MR and progressive loss of useful extremity function.
Caused by hypomethylation and consequently, DNA overactivity. |
|
If the deletion mutation 15q11-13 is inherited from the father, the patient has (Prader-Willi, Angelman's)
|
Prader-Willi
|
|
If the deletion mutation 15q11-13 is inherited from the mother, the patient has (Prader-Willi, Angelman's)
|
Angelman's
|
|
Triple Repeat Disorders can demonstrate anticipation. What is this and why?
|
Worsening of the disorder/earlier onset with successive generations. Due to expansion of the number of triple repeats during gametogenesis.
|
|
Huntington’s disease
Myotonic dystrophy Spinocerebellar ataxias Fragile X (common cause of hereditary mental retardation) Friedreich’s ataxia All have what in common? |
Triple repeat disorders.
|
|
heteroplasmy: defn
|
Inheritance of a variable number of mitochondria with mutation due to the fact that each cell contains many mitochondria (some of which may not have the mutation)
|
|
Mitochondrial diseases tend to affect what type of cells?
|
MtDNA diseases tend to affect cells that require large amounts of fuel (heavily dependent on oxidative phosphorylation)
Brain, muscle (especially cardiac) |
|
Mitochondrial diseases are associated with what symptoms?
|
diabetes
short status deafness Extreme variability in clinical expression both within and among families. |
|
Why is Duchenne muscular dystrophy more severe than Becker?
|
Duchenne is an entire deletion of dystrophin whereas Becker is a mutated dystrophin.
|
|
Allelic genetic heterogeneity: defn
|
Difference in severity of different disorders affecting the same gene, depending on how they affect the gene product. Duchenne vs. Becker muscular dystrophy is example.
|
|
nonallelic genetic heterogeneity: defn
|
Similar syndromes caused by mutations in different genes.
|
|
Charcot-Marie-Tooth (CMT) disease : symptoms
|
presents with clumsiness, ankle weakness, stumbling---later with hand weakness and sensory changes
|
|
Charcot-Marie-Tooth (CMT) disease : cause and utility of genetic testing.
|
mutations in genes expressed in Schwann cells and neurons.
A positive gene test can rule out other environmental and metabolic causes of neuropathy |
|
Inherited ataxias: utility of genetic testing
|
Reflects pathology in cerebellum and connecting pathways.
The clinician must decide if the pt has a degenerative condition, and order gene tests as appropriate |
|
Epilepsy: utility of genetic testing
|
Gene tests are helpful when there are gross abnormalities of the brain. But only a small number of epilepsy syndromes can be traced to mutations in proteins affecting ion channels (channelopathy)
|
|
Common autosomal dominant phakomatoses ones are associated with defects of _____ genes
|
tumor suppressor
|
|
Examples of phakomatoses
|
Von Hippel-Lindau
Neurofibromatosis Tuberous sclerosis Ataxia-telangiectasia |
|
Leukodystrophies: defn
|
refers to a group of disorders characterized by dysfunction of the white matter of the brain, characterized by problems with myelin sheath
|